Ying Piao

601 total citations
25 papers, 489 citations indexed

About

Ying Piao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ying Piao has authored 25 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Ying Piao's work include Renal cell carcinoma treatment (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Mechanisms and Therapy (3 papers). Ying Piao is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Mechanisms and Therapy (3 papers). Ying Piao collaborates with scholars based in China, New Zealand and United States. Ying Piao's co-authors include Xiaodong Xie, Yunen Liu, Xiaodong Xie, Yaling Han, Zhenyu Ding, Taidong Qiao, Yulei Du, Yu Han, Daiming Fan and Xiaoyin Zhang and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ying Piao

22 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Piao China 11 219 119 79 60 48 25 489
Man He China 8 216 1.0× 103 0.9× 105 1.3× 39 0.7× 49 1.0× 19 407
Jianlin Ren China 9 326 1.5× 127 1.1× 115 1.5× 51 0.8× 42 0.9× 18 578
Fatemeh Ahmadipour Malaysia 12 223 1.0× 136 1.1× 42 0.5× 36 0.6× 45 0.9× 19 546
Xinjia He China 15 190 0.9× 75 0.6× 75 0.9× 52 0.9× 56 1.2× 32 518
Yukai Xiang China 11 323 1.5× 100 0.8× 111 1.4× 60 1.0× 60 1.3× 20 515
Kang Cui China 11 242 1.1× 75 0.6× 101 1.3× 82 1.4× 40 0.8× 22 452
Yingchun Zhang China 14 171 0.8× 82 0.7× 47 0.6× 41 0.7× 46 1.0× 44 467
Masayoshi Fujisawa Japan 12 358 1.6× 105 0.9× 111 1.4× 44 0.7× 58 1.2× 53 751
Tseng‐Hsi Lin Taiwan 13 187 0.9× 82 0.7× 58 0.7× 37 0.6× 35 0.7× 19 480

Countries citing papers authored by Ying Piao

Since Specialization
Citations

This map shows the geographic impact of Ying Piao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Piao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Piao more than expected).

Fields of papers citing papers by Ying Piao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Piao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Piao. The network helps show where Ying Piao may publish in the future.

Co-authorship network of co-authors of Ying Piao

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Piao. A scholar is included among the top collaborators of Ying Piao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Piao. Ying Piao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yuji, et al.. (2026). Single‐Molecule All‐In‐One (SMALL) Dendritic Dots for Precise Cancer Theranostics. Advanced Materials. 38(18). e08639–e08639.
2.
Piao, Ying, et al.. (2025). Non-coding RNAs participate in interactions between senescence and gastrointestinal cancers. Frontiers in Genetics. 15. 1461404–1461404.
3.
Zhao, Wenhui, Jianli Ma, Qingyuan Zhang, et al.. (2024). Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. Cell Biology International. 48(4). 496–509. 6 indexed citations
4.
Gao, Xiaoli, et al.. (2024). Mapping the intellectual structure and emerging trends for the application of nanomaterials in gastric cancer: A bibliometric study. World Journal of Gastrointestinal Oncology. 16(5). 2181–2199. 2 indexed citations
5.
Zhang, Jun, Zhe Zhang, Meng Zhao, et al.. (2022). Protective effect and mechanism of cannabidiol on myocardial injury in exhaustive exercise training mice. Chemico-Biological Interactions. 365. 110079–110079. 26 indexed citations
6.
Piao, Ying, Ying Li, Qian Xu, et al.. (2015). Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer. PLoS ONE. 10(8). e0136447–e0136447. 34 indexed citations
7.
Xiao-dong, Xie, et al.. (2015). Meta-analysis of the association between APC promoter methylation and colorectal cancer. OncoTargets and Therapy. 8. 211–211. 15 indexed citations
8.
Xie, Xiaodong, Fei Guo, Tao Han, et al.. (2015). Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study. OncoTargets and Therapy. 8. 1581–1581. 5 indexed citations
9.
Piao, Ying, et al.. (2015). [Expression and clinical significance of MTDH and VEGF in triple-negative breast cancer].. PubMed. 37(11). 827–32. 3 indexed citations
10.
Du, Cheng, Wenchao Liu, Tao Han, et al.. (2014). MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway. BMC Cancer. 14(1). 869–869. 37 indexed citations
11.
Piao, Ying, et al.. (2014). Breast cancer metastasis to the stomach confirmed using gastroscopy: A case report. Oncology Letters. 8(3). 1205–1207. 10 indexed citations
12.
Tang, Dabei, Ying Piao, Shu Zhao, et al.. (2014). Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Medical Oncology. 31(7). 26–26. 27 indexed citations
13.
Piao, Ying, Yunen Liu, & Xiaodong Xie. (2013). Change Trends of Organ Weight Background Data in Sprague Dawley Rats at Different Ages. Journal of Toxicologic Pathology. 26(1). 29–34. 193 indexed citations
14.
Piao, Ying, et al.. (2013). EGF +61A>G polymorphism and gastrointestinal cancer risk: A HuGE review and meta-analysis. Gene. 519(1). 26–33. 15 indexed citations
15.
Guo, Fang, Xiaodong Xie, Xishuang Song, et al.. (2013). Prognostic analysis of Chinese patients with metastasic renal cell cancer (mRCC) receiving sorafenib: A multicenter retrospective study.. Journal of Clinical Oncology. 31(15_suppl). e15582–e15582. 1 indexed citations
16.
Wang, Lu, et al.. (2013). SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression. Cancer Cell International. 13(1). 88–88. 13 indexed citations
17.
Xu, Ying, Jingjing Jing, Yuehua Gong, et al.. (2011). Changes in biological and virulent characteristics of Helicobacter pylori exposed to high salt.. PubMed. 12(10). 2637–41. 7 indexed citations
18.
Xie, Xiaodong, et al.. (2009). [Clinical observation of 21 cases of metastatic renal cell carcinoma treated with sorafenib].. PubMed. 31(9). 714–5. 1 indexed citations
19.
Wang, Zhe, Rong Liang, Gaosheng Huang, et al.. (2006). Glucosamine sulfate–induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL. APOPTOSIS. 11(10). 1851–1860. 21 indexed citations
20.
Piao, Ying, Xiequn Chen, Limei Liu, et al.. (2005). [Reversion of multidrug resistance in HL-60/VCR cells by down-regulation of bcl-2 with bcl-2 siRNA].. PubMed. 13(6). 1010–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026